Brief: XSpray Pharma Gets Three New Patents In US
Feb 18 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* GETS THREE NEW PATENTS IN US FOR HYNAP-DASA
* UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HAS
GRANTED
XSPRAY THREE NEW US PATENT FOR HYNAP-DASA
* NEW PATENTS, US10,561,643; US 10,561,644; AND
US10,561,645, ARE
VALID UNTIL JANUARY 2033
* ALL PATENTS ARE VALID UNTIL JAN 2033
Source text for Eikon: ID:nWkr46dVBj
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xspray Pharma publ AB
See all newsBrief: Xspray Pharma Gets CRL From FDA
Sweden's Xspray Q1 loss narrows, upbeat on Dasynoc prospects
Brief: Xspray Pharma Q1 Pretax Loss SEK 35.4 Mln
Brief: Xspray Pharma To Receive About SEK 113 Million From Rights, Over-Allotment Issues
Brief: FDA Accepts Trade Name Nilopki For Xspray's Drug Candidate XS003